... Sector in India, 72 Technological Innovations in TB Control, 74 Potential Innovations and Action Items, 75 8 CONFRONTING CHALLENGES TO THE SUPPLY CHAIN FOR 77 SECOND-LINE DRUGS Challenges in ... (isoniazid and rifampicin), as well as any fluoroquinolone (levofloxacin, moxifloxacin, or ofloxacin) and at least one second-line injectable drug (kanamycin, amikacin, or capreomycin). Totally ... Tuberculosis: Challenges and Potential Solutions in India: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical ResearchINTRODUCTION...